<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xiao L</submitter><funding>NIDDK NIH HHS</funding><funding>NHGRI NIH HHS</funding><funding>American Diabetes Association</funding><funding>National Institutes of Health</funding><pagination>2207-2227.e9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11891809</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>36(10)</volume><pubmed_abstract>Brown adipose tissue (BAT) regulates systemic metabolism by releasing signaling lipids. N&lt;sup>6&lt;/sup>-methyladenosine (m&lt;sup>6&lt;/sup>A) is the most prevalent and abundant post-transcriptional mRNA modification and has been reported to regulate BAT adipogenesis and energy expenditure. Here, we demonstrate that the absence of m&lt;sup>6&lt;/sup>A methyltransferase-like 14 (METTL14) modifies the BAT secretome to improve systemic insulin sensitivity independent of UCP1. Using lipidomics, we identify prostaglandin E2 (PGE2) and prostaglandin F2a (PGF2a) as BAT-secreted insulin sensitizers. PGE2 and PGF2a inversely correlate with insulin sensitivity in humans and protect mice from high-fat-diet-induced insulin resistance by suppressing specific AKT phosphatases. Mechanistically, METTL14-mediated m&lt;sup></pubmed_abstract><journal>Cell metabolism</journal><pubmed_title>m&amp;lt;sup&amp;gt;6&amp;lt;/sup&amp;gt;A mRNA methylation in brown fat regulates systemic insulin sensitivity via an inter-organ prostaglandin signaling axis independent of UCP1.</pubmed_title><pmcid>PMC11891809</pmcid><funding_grant_id>K99 DK135927</funding_grant_id><funding_grant_id>RC2 DK139552</funding_grant_id><funding_grant_id>UC4 DK116278</funding_grant_id><funding_grant_id>R01 DK067536</funding_grant_id><funding_grant_id>P30 DK036836</funding_grant_id><funding_grant_id>RM1 HG008935</funding_grant_id><pubmed_authors>Ju CW</pubmed_authors><pubmed_authors>Tsuji T</pubmed_authors><pubmed_authors>He C</pubmed_authors><pubmed_authors>Mannisto V</pubmed_authors><pubmed_authors>Wei JB</pubmed_authors><pubmed_authors>Bluher M</pubmed_authors><pubmed_authors>DiStefano-Forti A</pubmed_authors><pubmed_authors>Cypess AM</pubmed_authors><pubmed_authors>Manninen SM</pubmed_authors><pubmed_authors>Xiao L</pubmed_authors><pubmed_authors>Pihlajamaki J</pubmed_authors><pubmed_authors>Hu J</pubmed_authors><pubmed_authors>Tseng YH</pubmed_authors><pubmed_authors>Wei S</pubmed_authors><pubmed_authors>Kulkarni RN</pubmed_authors><pubmed_authors>Cero C</pubmed_authors><pubmed_authors>Ijaduola O</pubmed_authors><pubmed_authors>De Jesus DF</pubmed_authors></additional><is_claimable>false</is_claimable><name>m&amp;lt;sup&amp;gt;6&amp;lt;/sup&amp;gt;A mRNA methylation in brown fat regulates systemic insulin sensitivity via an inter-organ prostaglandin signaling axis independent of UCP1.</name><description>Brown adipose tissue (BAT) regulates systemic metabolism by releasing signaling lipids. N&lt;sup>6&lt;/sup>-methyladenosine (m&lt;sup>6&lt;/sup>A) is the most prevalent and abundant post-transcriptional mRNA modification and has been reported to regulate BAT adipogenesis and energy expenditure. Here, we demonstrate that the absence of m&lt;sup>6&lt;/sup>A methyltransferase-like 14 (METTL14) modifies the BAT secretome to improve systemic insulin sensitivity independent of UCP1. Using lipidomics, we identify prostaglandin E2 (PGE2) and prostaglandin F2a (PGF2a) as BAT-secreted insulin sensitizers. PGE2 and PGF2a inversely correlate with insulin sensitivity in humans and protect mice from high-fat-diet-induced insulin resistance by suppressing specific AKT phosphatases. Mechanistically, METTL14-mediated m&lt;sup></description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-06-04T00:16:43.713Z</modification><creation>2026-05-03T03:12:00.385Z</creation></dates><accession>S-EPMC11891809</accession><cross_references><pubmed>39255799</pubmed><doi>10.1016/j.cmet.2024.08.006</doi></cross_references></HashMap>